Deutsche Bank’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-9,072
| Closed | -$1.2M | – | 4716 |
|
|
2020
Q4 | $1.2M | Buy |
9,072
+2,062
| +29% | +$272K | ﹤0.01% | 2317 |
|
|
2020
Q3 | $354K | Buy |
7,010
+765
| +12% | +$38.6K | ﹤0.01% | 2826 |
|
|
2020
Q2 | $297K | Buy |
6,245
+2,278
| +57% | +$108K | ﹤0.01% | 2880 |
|
|
2020
Q1 | $194K | Sell |
3,967
-618
| -13% | -$30.2K | ﹤0.01% | 2929 |
|
|
2019
Q4 | $262K | Buy |
4,585
+1,490
| +48% | +$85.1K | ﹤0.01% | 3023 |
|
|
2019
Q3 | $110K | Sell |
3,095
-1,788
| -37% | -$63.5K | ﹤0.01% | 3431 |
|
|
2019
Q2 | $149K | Sell |
4,883
-13,479
| -73% | -$411K | ﹤0.01% | 3900 |
|
|
2019
Q1 | $428K | Buy |
18,362
+12,283
| +202% | +$286K | ﹤0.01% | 3501 |
|
|
2018
Q4 | $83K | Sell |
6,079
-10,342
| -63% | -$141K | ﹤0.01% | 4116 |
|
|
2018
Q3 | $163K | Buy |
+16,421
| New | +$163K | ﹤0.01% | 4191 |
|